Analysed HCW BIOLOGICS INC (HCWB:NASDAQ) News Sources
E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
22-05-2026
yahoo.com
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
16-06-2026
yahoo.com
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
30-06-2026
yahoo.com
HCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
25-08-2026
yahoo.com
HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment
02-09-2026
yahoo.com
HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells
08-09-2026
yahoo.com
HCW Biologics Signs Akron Biotech Distribution Deal for CAR-T Manufacturing Reagent
08-09-2026
advfn.com
What is the current price of HCW BIOLOGICS INC (HCWB:NASDAQ)?
The current price of HCW BIOLOGICS INC (HCWB:NASDAQ) is $1.23.
HCW BIOLOGICS INC (HCWB:NASDAQ) absolute price change since previous trading day?
The absolute price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is $0.06.
HCW BIOLOGICS INC (HCWB:NASDAQ) percentage price change since previous trading day?
The percentage price change of HCW BIOLOGICS INC (HCWB:NASDAQ) since the previous trading day is 5.1282%.
What is the most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent average sentiment score for HCW BIOLOGICS INC (HCWB:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ)?
The most recent sentiment for HCW BIOLOGICS INC (HCWB:NASDAQ) is .
SEC-8K** Filing Available For HCW BIOLOGICS INC (HCWB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.